
Pot shares head higher in wager on U.S. legalization
CNBC’s Frank Holland stories on the deals being struck within the cannabis get as companies relate for doable legalization within the US. For access to live and authentic video from…

Curaleaf govt chairman on the future of the cannabis industry
Boris Jordan, Curaleaf govt chairman, joins ‘Assert on the Avenue’ to discuss regarding the future of the cannabis industry and where he sees the opportunity in market. For gather admission…

Reddit rally in the serve of pot stocks: Curaleaf’s Boris Jordan
CNBC’s “Verbalize on the Avenue” team discusses how retail investors keyed in on pot stocks with hashish firm Curaleaf government chairman Boris Jordan. For get accurate of entry to to…

Jim Cramer on investing within the cannabis and gambling sectors
CNBC’s Jim Cramer and David Faber take a look at in on the cannabis and gambling sectors.

White House pot news is all-in-all proper for the final country, says Curaleaf’s Boris Jordan
Boris Jordan, Curaleaf executive chairman, joins ‘Assert on the Avenue’ to discuss the importance of the White House’s marijuana news in the cannabis industry. On Thursday, President Joe Biden pardoned…

Jim Cramer on cannabis firms Aphria and Tilray merging
Hashish firms Aphria and Tilray will merge to receive the largest world cannabis company. CNBC’s Jim Cramer and David Faber discuss about. Subscribe to CNBC PRO for receive admission to…

Canada hits third anniversary of cannabis legalization
CNBC’s Frank Holland joins ‘Affirm on the Avenue’ from Toronto where he discusses the three-year anniversary of cannabis legalization in Canada. Frank Holland brings in David Klein, Cloak Hiss CEO,…

Europe will legalize marijuana over the subsequent twelve months or so: Tilray CEO
Irwin Simon, Tilray CEO, joins ‘Tell on the Boulevard’ to chat about why cannabis shares proceed to be below stress no subject worthwhile regulations, why investors aren’t seeing the aptitude…

Tailwinds will ultimately near for cannabis stocks: Canaccord Genuity’s Bottomley
Matt Bottomley, Canaccord Genuity analyst, joins ‘Relate on the Avenue’ to chat about Bottomley’s be taught on cannabis sector stocks, what occurs if regulations stumbles and additional. For safe admission…